Search research articles
Contact Us
Filters
Showing results (41-50 of 216) with videos related to
Page
of 22
Sort By:
Oncotarget
|
November 19, 2016
Quantification of tumor-derived cell free DNA(cfDNA) by digital PCR (DigPCR) in cerebrospinal fluid of patients with BRAFV600 mutated malignancies
Parisa Momtaz, Elena Pentsova, Omar Abdel-Wahab, et al.
Plos One
|
September 17, 2010
Alphavirus replicon particles expressing TRP-2 provide potent therapeutic effect on melanoma through activation of humoral and cellular immunity
Francesca Avogadri, Taha Merghoub, Maureen F Maughan, et al.
The American Journal of Dermatopathology
|
February 20, 2016
Protein Expression Analysis of Melanocyte Differentiation Antigen TRP-2
Francesca Avogadri, Sacha Gnjatic, Jodie Tassello, et al.
Oncoimmunology
|
September 14, 2016
Timing of CSF-1/CSF-1R signaling blockade is critical to improving responses to CTLA-4 based immunotherapy
Rikke B Holmgaard, Alexandra Brachfeld, Billel Gasmi, et al.
The Journal of Clinical Investigation
|
March 6, 2018
PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapy
Dmitriy Zamarin, Jacob M Ricca, Svetlana Sadekova, et al.
The Journal of Clinical Investigation
|
October 3, 2018
PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapy
Dmitriy Zamarin, Jacob M Ricca, Svetlana Sadekova, et al.
Cancer Research
|
December 3, 2008
Improved tumor immunity using anti-tyrosinase related protein-1 monoclonal antibody combined with DNA vaccines in murine melanoma
Yvonne M Saenger, Yanyun Li, Karoline C Chiou, et al.
Science Immunology
|
August 2, 2017
Intratumoral delivery of inactivated modified vaccinia virus Ankara (iMVA) induces systemic antitumor immunity via STING and Batf3-dependent dendritic cells
Peihong Dai, Weiyi Wang, Ning Yang, et al.
Science Translational Medicine
|
March 7, 2014
Localized oncolytic virotherapy overcomes systemic tumor resistance to immune checkpoint blockade immunotherapy
Dmitriy Zamarin, Rikke B Holmgaard, Sumit K Subudhi, et al.
The EMBO Journal
|
August 10, 2002
Maternally transmitted severe glucose 6-phosphate dehydrogenase deficiency is an embryonic lethal
Letizia Longo, Olga Camacho Vanegas, Meghavi Patel, et al.
Page
of 22
Search research articles
Search
Showing results (41-50 of 216) with videos related to
Sort By:
Page
of 22
Oncotarget
|
November 19, 2016
Quantification of tumor-derived cell free DNA(cfDNA) by digital PCR (DigPCR) in cerebrospinal fluid of patients with BRAFV600 mutated malignancies
Parisa Momtaz, Elena Pentsova, Omar Abdel-Wahab, et al.
Plos One
|
September 17, 2010
Alphavirus replicon particles expressing TRP-2 provide potent therapeutic effect on melanoma through activation of humoral and cellular immunity
Francesca Avogadri, Taha Merghoub, Maureen F Maughan, et al.
The American Journal of Dermatopathology
|
February 20, 2016
Protein Expression Analysis of Melanocyte Differentiation Antigen TRP-2
Francesca Avogadri, Sacha Gnjatic, Jodie Tassello, et al.
Oncoimmunology
|
September 14, 2016
Timing of CSF-1/CSF-1R signaling blockade is critical to improving responses to CTLA-4 based immunotherapy
Rikke B Holmgaard, Alexandra Brachfeld, Billel Gasmi, et al.
The Journal of Clinical Investigation
|
March 6, 2018
PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapy
Dmitriy Zamarin, Jacob M Ricca, Svetlana Sadekova, et al.
The Journal of Clinical Investigation
|
October 3, 2018
PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapy
Dmitriy Zamarin, Jacob M Ricca, Svetlana Sadekova, et al.
Cancer Research
|
December 3, 2008
Improved tumor immunity using anti-tyrosinase related protein-1 monoclonal antibody combined with DNA vaccines in murine melanoma
Yvonne M Saenger, Yanyun Li, Karoline C Chiou, et al.
Science Immunology
|
August 2, 2017
Intratumoral delivery of inactivated modified vaccinia virus Ankara (iMVA) induces systemic antitumor immunity via STING and Batf3-dependent dendritic cells
Peihong Dai, Weiyi Wang, Ning Yang, et al.
Science Translational Medicine
|
March 7, 2014
Localized oncolytic virotherapy overcomes systemic tumor resistance to immune checkpoint blockade immunotherapy
Dmitriy Zamarin, Rikke B Holmgaard, Sumit K Subudhi, et al.
The EMBO Journal
|
August 10, 2002
Maternally transmitted severe glucose 6-phosphate dehydrogenase deficiency is an embryonic lethal
Letizia Longo, Olga Camacho Vanegas, Meghavi Patel, et al.
Page
of 22